Leap Therapeutics Inc Capital Reinvestment Ratio

Latest as of June 2016: 0.01x

Leap Therapeutics Inc capital reinvestment ratio. Leap Therapeutics Inc (LPTX) has a Capital Reinvestment Ratio of 0.01x as of June 2016, meaning it reinvests 0% of its operating cash flow ($2.08 Million) in capital expenditures ($30.00K). Check LPTX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$2.08 Million

USD

Capital Expenditures

$30.00K

USD

Data as of

Jun 2016

Most recent filing

Leap Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Leap Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see LPTX cash flow metrics.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow